Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN14145737
ISRCTN14145737
Completed
Not Applicable

Visual acuity, additional correction reduction (for close-up and intermediate distances), visual disturbances rate, spectacles dependence, quality of life and personal satisfaction after phacoemulsification and implantation of SN6AD1, SN6AD3, FIL611PV and FIL618 intraocular lenses in patients affected by bilateral cataract

Institute of Ophthalmology0 sites60 target enrollmentFebruary 2, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCataractsEye Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataracts
Sponsor
Institute of Ophthalmology
Enrollment
60
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2017
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institute of Ophthalmology

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged over 50 years
  • •2\. Bilateral cataract
  • •3\. Maximum regular corneal astigmatism of 1\.0 D

Exclusion Criteria

  • •1\. Optical means opacities different from cataract
  • •2\. Age\-related macular degeneration
  • •3\. Previous history of ocular surgery
  • •4\. Irregular corneal astigmatism
  • •5\. Amblyopy
  • •6\. Concurrent neuro\-muscular diseases (i.e. cerebral ictus, myasthenia)
  • •7\. Uncontrolled open/close\-angle glaucoma
  • •8\. Severe ocular complications related to diabetes (i.e. retinopathy, macular edema, vitreal hemorrhage)
  • •9\. Intra/postoperative complications
  • •10\. Pupil diameter \= 5,2 mm in mesopic lighting conditions measured with a slit lamp\-based cobalt blue light method

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The Correlation for Improvement of Visual Acuity and QOL after Ranibizumab Treatment for Age-Related Macular Degeneration PatientsAge-related macular degeneration
JPRN-UMIN000012013Clinical Research Support Center Kyushu100
Completed
Not Applicable
Prediction of spectacle-corrected visual acuity of keratoconus eye using anterior eye OCTKeratoconus
JPRN-UMIN000033372Chukyo Eye Clinic200
Active, not recruiting
Not Applicable
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - NDSubfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatmentsMedDRA version: 6.1Level: PTClassification code 10060823
EUCTR2006-002424-42-ITOSPEDALE SACRO CUORE-DON CALABRIA150
Not yet recruiting
Phase 3
To compare two phakic intraocular lensesHealth Condition 1: H521- Myopia
CTRI/2023/03/050635Prof MVanathi
Not yet recruiting
Phase 4
Clinical trial of Zhixue Quyu Mingmu Tablet in the treatment of ocular fundus hemorrhage after its releaseSubmacular hemorrhage
ITMCTR2000003529Peking Union Medical College Hospital, Chinese Academy of Medical Sciences